Showing results (81-90 of 206) with videos related to
Sort By:
Pageof 21
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 2, 2017
Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D-Aromatic-Boron-Rich-Cluster into the 4-Anilinoquinazoline Scaffold: Potential Drugs for Glioma TreatmentMarcos Couto, María Fernanda García, Catalina Alamón, et al.Journal of Inorganic Biochemistry|October 10, 2006
DNA conformational changes and cleavage by ruthenium(II) nitrofurylsemicarbazone complexesLucía Otero, Pablo Smircich, Marisol Vieites, et al.Current Topics in Medicinal Chemistry|May 9, 2014
Mutagenicity of N-oxide containing heterocycles and related compounds: experimental and theoretical studiesMartin Gabay, Mauricio Cabrera, Rossanna Di Maio, et al.Bioorganic Chemistry|November 9, 2019
Identification and characterization of human interferon alpha inhibitors through a WISH cell line-based reporter gene assayMilagros Bürgi, Paola Hernández, Mauricio Cabrera, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|August 2, 2020
Bimodal Therapeutic Agents Against Glioblastoma, One of the Most Lethal Forms of CancerMarcos Couto, Catalina Alamón, Susana Nievas, et al.European Journal of Medicinal Chemistry|December 4, 2012
Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidatesPaola Hernández, Rosario Rojas, Robert H Gilman, et al.ACS Omega|December 26, 2022
Synthesis and Antitrypanosomal and Mechanistic Studies of a Series of 2-Arylquinazolin-4-hydrazines: A Hydrazine Moiety as a Selective, Safe, and Specific Pharmacophore to Design Antitrypanosomal Agents Targeting NO ReleaseAngel H Romero, Elena Aguilera, Lourdes Gotopo, et al.Future Medicinal Chemistry|October 5, 2019
Carboranylanilinoquinazoline EGFR-inhibitors: toward 'lead-to-candidate' stage in the drug-development pipelineMarcos Couto, Catalina Alamón, Carina Sánchez, et al.Archiv Der Pharmazie|February 14, 2006
Synthesis and characterization of thiol containing furoxan derivatives as coligands for the preparation of potential bioreductive radiopharmaceuticalsHugo Cerecetto, Mercedes González, Silvia Onetto, et al.Bioorganic & Medicinal Chemistry|July 14, 2007
Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterizationGloria V López, Fabiana Blanco, Paola Hernández, et al.Pageof 21